Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 126, 154911
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- ReplyHepatology Communications, 2019
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patientsHepatology, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- 379 Characteristics and Long-Term Prognosis of Lean Patients With Nonalcoholic Fatty Liver DiseaseGastroenterology, 2014
- Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver diseaseHepatology, 2011
- Diagnosis and management of the metabolic syndromeCurrent Opinion in Cardiology, 2006
- The metabolic syndrome—a new worldwide definitionThe Lancet, 2005
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Appropriate body-mass index for Asian populations and its implications for policy and intervention strategiesThe Lancet, 2004